English
Current trends in manufacturing for large volume parenteral in the pharmaceutical industry and future scopes
Tarang Patel
Vatsal Patel
Mehul Patel
Umang Shah
Ashish Patel
Swayamprakash Patel
Nilay Solanki
Abstract
The current features of manufacturing of Large Volume Parenteral from receiving the API and excipient to the final dispatch of product addressed many features including, sampling errors, manufacturing errors other controls, and individuals involved in various phases. The pharmaceutical industry nowadays places a greater focus on production-related issues like handling manpower and quality-related problems and implementing systems like Good Manufacturing Practises, and other systems. To reduce reliance on humans and raise the quality of products, future trends and possibilities in automation in various areas like production, quality assurance, and quality controls were discussed in this paper. For the production of an enormous quantity of parentals, the roles and responsibilities of both the manufacturing team and the quality assurance team are crucial. Future manufacturing initiatives can reduce labour expenses while enhancing product quality, nevertheless, they will also encourage more automation research and development.
Keywords:
Large Volume Parenteral, Quality Assurance, Production, Automation, Pharmaceutical industrySimilar Articles
- Agnieszka Kalicka, Natalia Tarłowska, Counterfeit and illegal medicinal products as an example of drugs that do not meet the basic quality requirements , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
- Karolina Księżarczyk, Bartłomiej Sankowski, SELECTED ASPECTS OF PARENTERAL NUTRITION , Prospects in Pharmaceutical Sciences: Vol. 15 No. 4 (2017)
- Sylwia Osowska, Joanna Regulska, Lipid peroxidation markers used in parenteral nutrition , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
- Michał Gackowski, Katarzyna Połomska, Natalia Szczucka, Mateusz Wylaź, Digital-based system as a tool for improving healthcare coordination - a perspective study , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
- Yunus Emre Kahraman, Yılmaz Çalışkan, A financial perspective on the pharmaceutical industry , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
- Ewa Napiórkowska, Overview of cyclodextrins and medicinal products containing cyclodextrins currently registered in Poland , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
- Krzysztof Adam Stępień, Jakub Niewiarowski, Anna Harasimiuk, PREVALENCE OF DIETARY SUPPLEMENTS AND THREATS ASSOCIATED WITH THEIR TAKING , Prospects in Pharmaceutical Sciences: Vol. 17 No. 9 (2019)
- Mateusz Sobczyk, Daria Żuraw, Paulina Oleksa, Kacper Jasiński, Mikołaj Porzak, Michał Dacka, SGLT2 inhibitors and their possible use in prevention and treatment of neurological diseases , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
- Arzu Birinci Yildirim, Ayca Cimen, Yavuz Baba, Arzu Turker, Natural- and in vitro-grown Filipendula ulmaria (L.) Maxim: evaluation of pharmaceutical potential (antibacterial, antioxidant and toxicity) and phenolic profiles , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
- Magdalena Makarewicz, Anna Łysiak, Katarzyna Łysiak, Barbara Maziarz, Evaluation of the effectiveness of platelet-rich plasma therapy in the treatment of osteoarthritis compared to other treatment methods , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
You may also start an advanced similarity search for this article.
Details
References
Statistics
Authors
Citation rules
Cited by / Share
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License.